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Brain tumors are the most common solid malignancy during childhood. 
Moreover, neoplasms of central nervous system (CNS) are the second leading 
malignancy in pediatric population, following tumors of the hematopoietic 
and lymphoid tissues (1, 2). These malignancies pose a significant burden to 
the health system and finding more cost-effective diagnostic and therapeutic 
Abstract
Objective 
Few studies exist on the demographics and trends of pediatric central nervous 
system (CNS) tumors in Iran. In this study, we retrospectively reviewed all cases 
with confirmed CNS tumors admitted to Mofid Pediatric Hospital, Tehran, Iran 
during the last 18 years. 
Materials & Methods
Data on gender, age of diagnosis, pathologic classification and tumor location 
were extracted from the available medical records. We used the last version of 
International Classification of Childhood Cancer.
Result
Overall, 258 (81.9%) brain tumors and 57 (18.1%) spinal tumors were identified. 
Our subjects comprised of 147 (46.7%) female and 168 (53.3%) male children. 
More male dominancy was observed in brain tumors with a male to female ratio 
of 1.2 compared with 1.03 of spinal tumors. Malignant CNS tumors were most 
common in 1-4 yr age group. The four most common brain tumors in our subjects 
were astrocytomas, medulloblastoma, ependymoma and craniopharyngioma. 
Overall, 53.1% of the brain tumors were supratentorial. Gliomas, PNET and 
neuroblastma were the most frequent primary spinal tumors in our study. We 
observed an increasing trend for both brain and spinal tumors that was more 
remarkable in the last 5 years.
Conclusion
Our results are comparable with similar single center studies on CNS tumors 
during childhood. The observed disparities could be attributed to the single 
center nature of our study and geographical, environmental and racial variations 
in pediatric CNS tumors. The increasing trend of both brain and spinal tumors 
could warrant further investigations at provincial and national levels to 
investigate probable contributing environmental risk factors.
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management options is of utmost importance. 
Use of novel diagnostic and therapeutic options 
based on advanced molecular approaches has been 
promising in this regard (3). However, despite notable 
technological improvements, optimal management of 
childhood CNS malignancies remains a significant 
challenge in pediatric neuro-oncology, particularly in 
the less developed countries (4, 5).
Various epidemiologic investigations on pediatric 
CNS malignancies have been published, highlighting 
the possible geographical and racial variations of 
these diverse disease categories (6-8). Use of different 
classification methodologies in cancer registries and 
change of tumor subtypes over time have further 
complicated the interpretation of observed variations 
among different investigations. In addition, some 
studies have reported increasing trends of childhood 
brain tumors; yet this increased incidence has been 
attributed to the improved diagnostic capabilities 
rather than an actual change in annual incidence rate 
(9).
Few studies exist on the demographics and trends of 
pediatric CNS neoplasms in Iran. In this study, we 
retrospectively reviewed all cases of CNS tumors 
admitted to Mofid Pediatric Hospital during the last 
18 years. Our results on demographic variations of 
different tumor categories and trends of CNS tumors 
could provide further insight to implement more 
evidence-based policies regarding pediatric neuro-
oncology in Iran.
Materials & Methods
In this study, we extensively reviewed all cases with 
confirmed diagnosis of CNS tumors admitted to Mofid 
Pediatric Hospital, Tehran, Iran from March 1996 
to March 2013. Data on gender, age of diagnosis, 
pathologic classification and location of tumors 
were extracted from the available medical records. 
We used the last published version of International 
Classification of Childhood Cancer (ICCC), used by 
The Surveillance, Epidemiology, and End Results 
(SEER) program in the United States (10). This 
classification system is based on tumor morphology 
and primary site, with an emphasis on morphology. 
In cases of altered diagnostic categories, pathologic 
blocks were re-examined by a specialist in pediatric 
pathology and tumors were reclassified accordingly. 
Moreover, in cases of diagnostic uncertainty, 
diagnosis was confirmed by immunohistochemistry 
(IHC).  All duplicate cases and those with incomplete 
data or uncertain pathologic diagnosis were excluded.
Statistical analyses were performed using SPSS 
version 16 (Chicago, IL, USA). For categorical and 
continuous variables, Chi-square and student t-test 
were used respectively. P-values less than 0.05 
were regarded as statistically significant. Institution 
Review Board (IRB) in Pediatric Infectious Research 
Center approved the study protocol according to the 
Declaration of Helsinki. 
Results
In this study, we managed to collect demographic data 
on 315 pediatric CNS tumors during the last 18 years. 
Overall, 258 (81.9%) brain tumors and 57 (18.1%) 
spinal tumors were identified. Our subjects comprised 
of 147 (46.7%) female and 168 (53.3%) male children 
with an overall 1.14 male to female ratio. Gender 
distribution was 117 (45.3%) females vs. 141 (54.6%) 
males and 28 (49.1%) females vs. 29 (50.1%) males 
for brain and spinal tumors, respectively. More male 
dominancy was observed in brain tumors with a male 
to female ratio of 1.2 compared with 1.03 of spinal 
tumors. The mean (SD) age of diagnosis was 5.5 yr 
(4.0) and 5.2 yr (4.3) for subjects with brain and spinal 
tumors, respectively. Both brain and spinal tumors 
were more frequent in 1-4 year age group with the 
following frequencies, 89 (34.5%) and 23 (40.4%) in 
that order. Mean age of diagnosis did not significantly 
differ between genders.  
Gliomas were the most common diagnosed primary 
brain tumor among the subjects and frequency of 
different subtypes was as follows: ependymoma 32 
(12.4%), pilocytic astrocytoma 28 (10.9%), low grade 
astrocytoma 26 (10.1%), glioblastoma multiforme 9 
(3.5%), unspecified gliomas 8 (3.1%), mixed neuronal-
glial tumors 6 (2.3%), ependymoblastoma 5 (1.9%), 
astroblastoma 1 (0.4%) and oligodendroglioma 1 
(0.4%). Following gliomas, embryonal tumors were the 
second leading primary brain tumor among the subjects 
with the following frequencies: medulloblastoma 52 
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(20.2%), Primitive neuroectodermal tumour (PNET) 
16 (6.2%) and rhabdoid tumors 3 (1.2%). Other 
primary brain tumors were observed with following 
order of frequency: craniopharyngioma 17 (6.6%), 
meningioma 12 (4.5%), choroid plexus papilloma 8 
(3.1%), lymphoma 7 (2.7%) and pineal parenchymal 
tumors 5 (1.9%). Overall, 19 (7.4%) metastatic brain 
tumors were identified and the most common source 
of metastasis were neuroblastoma and malignant 
germ cell tumors. 
Most common brain tumors were most frequent in 0-3 
year age group, 19 (30.1%) of astrocytoma, 21 (40.4%) 
of medulloblastoma and 18 (56.2%) of ependymoma 
cases were detected in 0-3 yr age groups. The average 
age of diagnosis and gender distribution of different 
brain tumor categories are listed in Tables 1 and 2.
Overall, 137(53.1%) and 121 (46.9%) of brain tumors 
were supratentorial and infratentorial, respectively. 
Most common supratentorial brain tumors were 
astrocytoma 22 (18.2%), craniopharyngioma 17 (14%) 
and PNET 16 (13.2%).  Most common infratentorial 
tumors were medulloblastoma (38%), astrocytoma 41 
(30%) and ependymoma 28 (20.5%).
Gliomas were also the most common diagnosed 
primary spinal tumor among the subjects with the 
following observed frequency in different pathologic 
subgroups; astrocytoma 5 (8.8%), unspecified 
gliomas 3 (5.3%), pilocytic astrocytoma 2 (3.5%), 
ependymoma and ependymoblastoma with similar 
frequency of 1 (1.8%). Following gliomas, PNET 
and neuroblastoma were the most common primary 
spinal tumors with similar frequency of 7 (12.2%), 
followed by meningioma with frequency of 6 
(10.5%). Metastatic spinal cancers were common 
and 19 (33.3%) of these cases were identified mostly 
metastasized from neuroblastoma, germ cell tumors, 
Ewing’s sarcoma and rhabdomyosarcoma. 
Regarding the age of diagnosis of most frequent 
spinal tumors, 3 (42.9%) of astrocytic tumors were 
distributed in 0-3 and 9-12 yr age groups, 3 (42.9%) 
of PNET cases and 4 (66.7%) of meningiomas were 
detected in 6-9 and 12-15 yr age groups, respectively. 
The average age of diagnosis and gender distribution 
of subjects with spinal tumors are listed in Tables 3 
and 4.
The overall trend of brain and spinal tumors were 
increasing. Number of brain tumors almost doubled 
from 17 (6.5%) cases in 2009 to 29 (11.2%) cases 
in 2010. Following 2010 most frequent brain tumors 
were identified in 2013 and 2011 with the frequency 
of 24 (9.3%) and 22 (8.5%). This increasing trend was 
more dramatic for spinal tumors and the identified 
cases were almost quadrupled from 2 (3.5%) cases in 
2009 to 8 (14%) cases in 2010. Following 2010 spinal 
tumors were most frequent in 2011 and 1998 with 
frequency of 7 (12.2%) and 6 (10.5%), respectively. 
Detailed trends of brain and spinal tumors are 
illustrated in Figures 1 and 2.
Discussion
In this study, we retrospectively reviewed 315 cases 
of confirmed CNS tumors admitted to Mofid Pediatric 
Hospital in the last 18 years. Our findings regarding 
the most common brain and spinal tumors, gender 
distribution and age of diagnosis were comparable 
with other national and global reports.
According to statistics published by SEER Program 
of the National Cancer Institute in the United States, 
CNS tumors are the leading solid malignancy during 
childhood (11). Male preponderance is a known fact 
in pediatric brain tumors (12). Sexual dimorphism 
in tumor biology could account for this gender 
disparity and detailed mechanisms regarding role 
of sex hormones and sex chromosomes on brain 
tumorigenesis are areas of ongoing investigations 
(13). Previous studies in Iran reported 1.2 and 1.68 
male to female ratio in pediatric brain tumors (14, 
15). In our study, male to female ratio was 1.2 for 
brain tumors, which is comparable with Australian 
(16), German (17), Canadian (18) and US studies, but 
is less than 1.6 ratio reported in a large single center 
study in China (6).
In this study, malignant CNS tumors were most 
common in 1-4 yr age group. In annual age-adjusted 
rates published based on SEER database, most 
common age of diagnosis of pediatric brain tumors 
were 1-4 yr age group as well (19).
The four most common brain tumors in our study 
were astrocytomas, medulloblastoma, ependymoma 
and craniopharyngioma. This pattern matches the 
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largest national report (14), a recent single center 
study in Australia (16) and is comparable with the 
retrospective report of 1485 cases in China (6), with 
higher frequency of medulloblastoma in our subjects. 
High frequency of low-grade astrocytic tumors in 
our subjects also matches the published studies on 
pediatric brain tumors (20, 21). However, changes 
in pathological classification of pediatric CNS 
tumors have played a remarkable role in observed 
variations and apparent changes of trend of some 
tumor categories, particularly pilocytic astrocytoma 
(22). The observed frequency of ependymoma was 
also compatible with established reports that estimate 
an approximate 10% prevalence of ependymomas in 
pediatric intracranial tumors. In subjects under 3 years 
of age, the vast majority of ependymomas were also 
located at the posterior fossa, which is in line with the 
typical demographics of this tumor category in this 
age group (23). Medulloblastoma comprised 20.2% of 
brain tumors in our sample and this finding is also in 
line with epidemiologic investigations that highlight 
similar frequency of this tumor category as the most 
common malignant pediatric CNS tumor (7). Much 
lower frequency of medulloblastoma was reported 
by a large single center study in Australia, which 
is noteworthy (16). Moreover, following astrocytic 
tumors and medulloblastoma, craniopharyngioma 
was the most common tumor in our sample and this 
pattern of frequency matches most studies in pediatric 
brain malignancies (24).
Review of the literature suggests that about one-
half to two-thirds of pediatric brain tumors are 
supratentorial. Statistics based on Central Brain 
Tumor Registry of the US (CBTRUS) data, highlight 
an even distribution of supratentorial and infratentorial 
tumors in children (20). In our subjects, 53.1% of the 
tumors were supratentorial, which is lower than the 
62% rate observed in the Chinese single center study 
(6). In contrast to these findings, majority of tumors 
(67.7%), were infratentorial in a recent study on cases 
admitted to MAHAK’s Pediatric Cancer Treatment 
and Research Center in Iran (15).
Gliomas, PNET and neuroblastma were the most 
primary spinal tumors in our study. This is comparable 
with another study in a large referral center study that 
reported neurodevelopmental tumors, astrocytomas 
and neuroblastomas as the most common diagnostic 
categories in a retrospective review (25). However, 
the unusual high frequency of neurdevelopmental 
tumors including dermoid tumors and teratomas in 
that study is in contrast to several published reports. 
The most common spinal tumors in the Chinese study 
were ependymal tumors and schwanomas followed 
by astrocytic tumors (6). Similar to Wilson et al. (25) 
we found very low frequency of ependymal tumors 
compared to similar single center studies (6, 26). Our 
subjects were younger than 15 years old and it is well 
established that ependymomas of the spinal cord occur 
more often in the adult population (27). This observed 
disparity between various reports on demographics 
of pediatric spinal tumors has been attributed to the 
low prevalence of spinal masses in children (28). 
Moreover, we did not observe a gender predilection 
in spinal tumors, which is in line with reports on this 
topic in the literature (28, 29). Spinal metastases were 
mostly caused by neuroblastoma, germ cell tumors, 
Ewing’s sarcoma and rhabdomyosarcoma that could 
be compared with previous studies (30).
The increasing trend observed in this retrospective 
review should be interpreted with caution and in the 
context of possible referral biases introduced by the 
single center nature of this study. However, it could 
warrant further analyses at provincial and national 
levels to detect probable changes in the overall trend 
of pediatric CNS tumors. The existing literature 
highlights the improvements in the diagnostic 
sensitivity due to increased availability of magnetic 
resonance imaging as a crucial contributor in this 
apparent increasing trend of CNS tumors (22). In 
addition, factors like changes of tumor classifications 
and increased exposure to the known and unidentified 
environmental risk factors should be considered and 
thoroughly investigated as other possible contributing 
factors.
In conclusion, in this retrospective 18-year review 
in a large referral pediatric center, we described 
demographics of CNS tumors in 315 subjects. Our 
results on demographics are comparable with similar 
single center studies on this topic with disparities that 
could be attributed to the single center nature of our 
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This retrospective review was conducted using 
the medical records available at the department of 
pediatric pathology at Mofid Children’s Hospital 
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study and geographical, environmental and racial 
variations in childhood CNS tumors. The increasing 
trend of pediatric CNS tumors could warrant further 
investigations at provincial and national levels to 
investigate probable contributing environmental risk 
factors. Furthermore, the demographic data presented 
in this study could be used as a reliable profile to 
set priorities for rationing the limited resources, 
particularly at large referral pediatric hospitals. 
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Table 1. Detailed Distribution Of Brain Tumors between Genders
Tumor category  Female N (%)  Male N (%)
Ependymoma 19 (59.4) 13 (40.6)
Ependymoblastoma 3 (60) 2 (40)
Choroid plexus papilloma 4 (50) 4 (50)
Astrocytomas 11 (37.9) 18 (62.1)
Pilocytic astrocytoma 18 (64.3) 10 (35.7)
Glioblastoma multiforme 5 (55.6) 4 (44.4)
Oligodendroglioma 0 (0) 1 (100)
Unspecified gliomas 7 (87.5) 1 (12.5)
Astroblastoma 0 (0) 1 (100)
Mixed neuronal-glial tumors 3(42.8) 4 (57.2)
Medulloblastoma 16 (30.2) 37 (69.8)
PNET 8 (50) 8 (50)
Atypical teratoid/rhabdoidtumor 1 (33.3) 2 (66.7)
Craniopharyngioma 9 (52.9) 8 (47.1)
Pineal parenchymal tumors 2 (40) 3 (60)
Meningioma 4 (44.4) 5 (55.6)
Angioblastic meningioma 1 (100) 0 (0)
Atypical meningioma 2 (100) 0 (0) 
Lymphoma 1 (25) 3 (75)
Metastasis 7 (36.9) 12 (63.1)
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Table 2. Age of Diagnosis -Brain Tumors
Tumor category  Age Mean±(SD) (yr)
Ependymoma 4.3±(4)
Ependymoblastoma 2±(2.2)






Astroblastoma 1.00 0 ±(0)
Mixed neuronal-glial tumors 7.6 ±(4.7)
Medulloblastoma 5.4 ±(3.5)
PNET 4.2 ±(3.5)
Atypical teratoid/rhabdoidtumor 1.5 ±(0.8)
Craniopharyngioma 9.0±(2.6)
Pineal parenchymal tumors 12 ±(2.1)
Meningioma 12±(2.2)
Angioblastic meningioma 6 ±(0)
Atypical meningioma 0.2 ±(0.1)
Lymphoma 3.8 ±(2.8)
Metastasis 4.6±(1.3 ) 
Table 3. Detailed Distribution of Spinal Tumors Between Genders
Tumor category  Female n (%)  Male n (%)
Ependymoma 0 (0) 1 (100) 
Ependymoblastoma 0 (0) 1 (100)
Astrocytomas 3 (60.0) 2 (40.7)
Pilocytic astrocytoma 1 (50) 1 (50)
Unspecified gliomas 3 (100) 0 (0) 
PNET 2 (28) 5 (72)
Meningioma 2 (33.3) 4 (66.7)
Neuroblastoma 3(42.9) 4(57.1)
Ganglioneuroblastoma  0 (0) 2 (100)
Ganglioneuroma 2 (100) 0 (0) 
Spindle cell tumor 0 (0) 1 (100)
Hemangioblastoma 1 (100) 0 (0) 
Metastasis 11(57.9) 8(42.1)
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Table 4. Age of DIAGNOSIS -SPINAL TUMORS








Neuroblastoma 1.9± (0.7) 
Ganglioneuroblastoma 4±(0)
Ganglioneuroma 5±(0.7)
Spindle cell tumor 6±(0)
Hemangioblastoma 11±(0)
Metastasis 3.2±(2.3)
Fig 1. Trend of pediatric brain tumors
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